These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2940946)

  • 21. Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker.
    Allegra C; Tonelli V; Bonifacio M; Mari A; Assogna G
    Boll Chim Farm; 1985 Oct; 124(10):121S-124S. PubMed ID: 2935173
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
    Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
    Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of serotonergic blockade in postpartum preeclamptic patients.
    Montenegro R; Knuppel RA; Shah D; O'Brien WF
    Am J Obstet Gynecol; 1985 Sep; 153(2):130-4. PubMed ID: 2931024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serotonin antagonists in the treatment of hypertension].
    Fetkovská N; Brimichová G; Tison P; Dzúrik R
    Cas Lek Cesk; 1984 Mar; 123(11):322-5. PubMed ID: 6367991
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of ketanserin in essential hypertension.
    Anderson A; Morgan T; Dumpys R
    Clin Exp Pharmacol Physiol; 1983; 10(3):331-3. PubMed ID: 6627748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healing effect of ketanserin on chronic leg ulcers in patients with diabetes.
    Quatresooz P; Kharfi M; Paquet P; Vroome V; Cauwenbergh G; Piérard GE
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):277-81. PubMed ID: 16503887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of ketanserin pretreatment on the haemodynamic responses to sternotomy.
    Cashman JN; Thompson MA; Bennett A
    Anaesthesia; 1986 May; 41(5):505-10. PubMed ID: 2942050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of serotonin-receptor blockade after cardiopulmonary by-pass. A pilot study.
    Miranda DR; Stoutenbeek CP; Zandstra D; Alexander JP
    Acta Anaesthesiol Belg; 1982; 33(1):63-8. PubMed ID: 7090727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of oxygen, nifedipine and ketanserin in hypoxic pulmonary hypertension.
    Hamet A; Král B; Cernohorský D
    Cor Vasa; 1985; 27(6):406-11. PubMed ID: 2936568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative study of the effects of Ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled investigation and an additional long term open trial.
    van de Wal HJ; Wijn PF; van Lier HJ; Skotnicki SH
    Microcirc Endothelium Lymphatics; 1985; 2(6):657-85. PubMed ID: 2942753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antihypertensive effects of a pure and selective serotonin-receptor blocking agent (R 41 468) in elderly patients.
    De Cree J; Leempoels J; De Cock W; Geukens H; Verhaegen H
    Angiology; 1981 Feb; 32(2):137-44. PubMed ID: 7011110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does ketanserin relieve frostbite?
    Vayssairat M; Priollet P; Hagege A; Housset E; Foray J
    Practitioner; 1986 May; 230(1415):406-8. PubMed ID: 2944086
    [No Abstract]   [Full Text] [Related]  

  • 33. Peripheral arterial diseases: treatment with ketanserin as i.v. infusion. An open study in 20 patients.
    Di Giovanni V; Colli R
    Boll Chim Farm; 1985 Oct; 124(10):129S-132S. PubMed ID: 2935175
    [No Abstract]   [Full Text] [Related]  

  • 34. Prophylactic use of ketanserin in a patient with carcinoid syndrome.
    Fischler M; Dentan M; Westerman MN; Vourc'h G; Freitag B
    Br J Anaesth; 1983 Sep; 55(9):920. PubMed ID: 6615683
    [No Abstract]   [Full Text] [Related]  

  • 35. [Regional drug-induced sympathicolysis in patients with arterial occlusive disease].
    Heimig T; Scheffler A; Rieger H; Acevedo A
    Wien Med Wochenschr; 1993; 143(7-8):184-5. PubMed ID: 8379171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketanserin: a selective serotonin antagonist.
    Lancet; 1982 Oct; 2(8303):859. PubMed ID: 6126719
    [No Abstract]   [Full Text] [Related]  

  • 37. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
    J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemodynamic effects of ketanserin either alone or with oxygen in COPD patients with secondary pulmonary hypertension.
    Domenighetti G; Leuenberger P; Feihl F
    Monaldi Arch Chest Dis; 1997 Oct; 52(5):429-33. PubMed ID: 9510660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of serotonin and its antagonists in anesthetic and surgical stress].
    Carrasco MS; de Castro J; Arroyo JL
    Rev Esp Anestesiol Reanim; 1983; 30(2):65-8. PubMed ID: 6878802
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular effects of ketanserin in closed-chest anesthetized dogs.
    van de Water A; Wouters L; Xhonneux R; Reneman S
    Arch Int Pharmacodyn Ther; 1985 Jun; 275(2):267-78. PubMed ID: 3161481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.